Stryker Recalls Reprocessed Coronary Sinus Diagnostic Catheters
Stryker Sustainability Solutions is recalling 2,722 reprocessed Coronary Sinus Diagnostic EP Catheters because thrombogenicity tests showed they did not meet non-thrombogenic specifications.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a medical device with a failure to meet non-thrombogenic specifications, which poses a risk of harm (thrombosis) even though no injuries are reported, fitting the 'High' severity criteria for risk-of-harm products.
Plain-English summary
Stryker Sustainability Solutions is recalling 2,722 units of the Coronary Sinus (CS) Uni-Directional Diagnostic Electrophysiology (EP) Catheter, catalog numbers D135303 and D135304. These reprocessed catheters are indicated for electrophysiological mapping of cardiac structures, specifically for stimulation and recording in the coronary sinus.
The recall was initiated because thrombogenicity test results demonstrated that both the test devices and control devices did not meet the internal specification of being non-thrombogenic. The affected units were distributed worldwide, including US Nationwide and Canada.
Healthcare providers should stop using the affected catheters and contact Stryker Sustainability Solutions for further instructions. The source text does not report any specific illnesses or injuries associated with this recall.
The recalled product
- Product
- Coronary Sinus (CS) Uni-Directional Diagnostic Electrophysiology (EP) Catheter, catalog numbers D135303 and D135304. Product Usage: The Reprocessed CS Diagnostic EP Catheter is indicated for electrophysiological mapping of cardiac structures; i.e., stimulation and recording o
- Manufacturer
- Stryker Sustainability Solutions
- Hazard
- Affected units
- 2,722
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Stryker Sustainability Solutions
See all →- HighDaig Livewire Steerable Electrophysiology Catheter Sterile Seal Defect Recall
FDA (Devices) · 2026-05-20
- HighReprocessed electrophysiology catheters recalled over incomplete sterile seals
FDA (Devices) · 2026-05-20
- HighReprocessed Electrophysiology Catheter Recalled for Incomplete Seals
FDA (Devices) · 2026-05-20
- HighDaig Livewire Steerable Electrophysiology Catheters Recalled for Incomplete Seals
FDA (Devices) · 2026-05-20
- HighReprocessed Electrophysiology Catheter Recalled for Incomplete Sterile Seals
FDA (Devices) · 2026-05-20
Same hazard · thrombosis
See all →- SevereLVIS Intraluminal Support Device Stent Recalled Dimensional Nonconformance
FDA (Devices) · 2026-05-20
- SevereMedtronic Pipeline Vantage Embolization Device Recall for Structural Deformation Risk
FDA (Devices) · 2025-03-12
- SevereFDA Recalls Mahurkar Dialysis Catheter for Potential Tip Obstruction Risk
FDA (Devices) · 2023-08-23
- SevereDialysis Catheter Recall Due to Center Lumen Occlusion
FDA (Devices) · 2023-08-23
- SevereDialysis catheters recalled for potential center lumen obstruction
FDA (Devices) · 2023-08-23